New EU pharmaceuticals rules in a strong European Health Union
Since 2020, the COVID pandemic altered every part of our lives, our societies, and our economies. It caught the world
Read more
Health
The lessons EU learned from the pandemic towards a better prepared and resilient pharmaceutical system
The COVID-19 crisis has pushed health higher on the agenda of the European Union, but also on the list of
Read more
Strengthening health in Europe after the COVID crisis and through an ambitious pharmaceutical strategy
Energy system integration in Europe – Decarbonization of the European economy
Read more
Boosting CRISPR-Cas as a solution to climate change and biodiversity conservation in the EU
Climate change keeps deteriorating, biodiversity loss has transgressed safe limits and conservation challenges are fast developing. Adverse feedbacks on agriculture
Read more
Basing the European Green Deal’s aspirations for packaging and circularity on evidence and facts
The fibre-based packaging industry is a key contributor to the European Green Deal’s aspiration to build a strong, circular and
Read moreGoing the Extra Mile to Turn Science into Reality for Patients in Europe
The pandemic proved that necessity truly is the mother of invention and furthermore demonstrated the critical need to ensure a
Read more
For a pharmaceutical strategy promoting health security
The pandemic has put Europe in the mirror, and forced us to reorganise our priorities. We have learned from our
Read more
Strengthening Europe’s capacity to anticipate and respond rapidly to cross-border health emergencies
In the past 10 years, the world has witnessed some of the deadliest outbreaks of infectious diseases in modern times,
Read more